In addition, rs11466445 in TGFBR1 , although being borderline significant in EPICOLON phase 1, was not genotyped in phase 2 because of incompatibility with the used high-throughput technology.
← all excerpts
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.
2
—
—
The sentences
Our results in the first phase showed a borderline significant association (unadjusted P -value =0.0491, dominant inheritance) but did not reach statistical significance after multiple-testing correction, suggesting that rs11466445 does not increase CRC risk.